ATAI LIFE SCIENCES LUXEMBOURG S.A.

EDGAR

Annual consolidated revenue for 2025: about USD 4.089M, using the latest reported figures. The previous period, 2024, was about USD 308K.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
6 transactions, 374,752 shares
Sum of shares × price per share: 1,660,303.296

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-09-11 JOHNSON SABRINA MARTUCCI D 64,000 —
  • 2026-09-11 JOHNSON SABRINA MARTUCCI D 64,000 —
  • 2026-09-11 JOHNSON SABRINA MARTUCCI D 103,000 —
  • 2026-09-11 JOHNSON SABRINA MARTUCCI D 103,000 —
  • 2026-09-11 JOHNSON SABRINA MARTUCCI D 121,968 —

5% holders (Schedule 13D and 13G)

  • Apeiron Investment Group Ltd. 0.0% SCHEDULE 13D/A 09/11/2026
  • Apeiron Presight Capital Fund II, L.P. 0.0% SCHEDULE 13D/A 09/11/2026
  • Presight Capital Management I, L.L.C. 0.0% SCHEDULE 13D/A 09/11/2026

See all insider transactions

Latest quarter

Revenue

1.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-2,590.43%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -44141000 USD Source
  • Revenue: 1704000 USD Source

Operating cash flow

-35.3 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -56363000 USD Source
  • Operating Cash Flow: -21090000 USD Source

Free cash flow

-35.3 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -56363000 USD Source
  • Operating Cash Flow: -21090000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
169 million USD Source
Exact value

168800000 USD

Long-term debt including current maturities
0 USD
Exact inputs and evidence

0 USD

  • Long-term debt including current maturities: 0 USD Source
Shares outstanding
369 million shares Source
Exact value

369214760 shares

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-11.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: 2 of 11 periods available· newest 2025-12-31
  • Total liabilities: 2 of 11 periods available· newest 2025-12-31
  • Current assets: 2 of 11 periods available· newest 2025-12-31
  • Current liabilities: 2 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2025-12-31
  • Shares outstanding: 2 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +1,227.6%

    Prior period

    USD 308,000

    –

    Current period

    USD 4.09 million

    –

    Exact inputs and evidence

    4089000 − 308000 = 3781000 USD

    308000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    4089000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 510.78 million

    Prior period

    −USD 149.27 million

    –

    Current period

    −USD 660.05 million

    –

    Exact inputs and evidence

    -660047000 − -149269000 = -510778000 USD

    -149269000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -660047000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 20.24 million

    Prior period

    −USD 82.44 million

    –

    Current period

    −USD 102.68 million

    –

    Exact inputs and evidence

    -102675000 − -82437000 = -20238000 USD

    -82437000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -102675000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +14,916.7%

    Prior period

    USD 6,000

    –

    Current period

    USD 901,000

    –

    Exact inputs and evidence

    901000 − 6000 = 895000 USD

    6000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    901000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 4.09 million 100% of revenue
  • Operating costs Derived USD 648.15 million 15,851% of revenue
  • Operating income −USD 644.06 million −15,751% of revenue
  • Tax, interest and other Derived USD 15.99 million 391% of revenue
  • Net income −USD 660.05 million −16,142% of revenue

Cash

  • Operating cash flow −USD 102.68 million −2,511% of revenue
  • Capital expenditure USD 901,000 22% of revenue
  • Free cash flow Derived −USD 103.58 million −2,533% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 33,441% of revenue.
  • 2025 Operating loss: operating costs were 15,851% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-31308000 102999000 Derived -102691000 46578000 Derived -149269000 -82443000 Derived
Source
2025 2025-01-01 – 2025-12-314089000 648150000 Derived -644061000 15986000 Derived -660047000 -103576000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.1M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.4M3.3M2.2M1.1M0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Revenue308000
2025Revenue4089000

Revenue growth

Change in revenue from the same financial period one year earlier.

1,227.6% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,326%994%663%331%0%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year1,227.6%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -15,751.1% 2025
Net margin -16,142% 2025
Free cash flow margin -2,533% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3,877%-10,177%-24,232%-38,287%-52,341%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-33,341.2%
2025Operating margin-15,751.1%
2024Net margin-48,464%
2025Net margin-16,142%
2024Free cash flow margin-26,767.2%
2025Free cash flow margin-2,533%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -102.7M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.2M-21.6M-51.3M-81.1M-110.9M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Operating cash flow-82437000
2025Operating cash flow-102675000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -103.6M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.3M-21.8M-51.8M-81.8M-111.9M20242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Free cash flow-82443000
2025Free cash flow-103576000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

24.2% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.29.0%21.8%14.5%7.3%0.0%20242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024Liabilities / assets26.9%
2025Liabilities / assets24.2%

Current assets to current liabilities

Current assets divided by current liabilities.

11.74× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.68×9.51×6.34×3.17×0.00×20242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024Current assets / current liabilities3.21×
2025Current assets / current liabilities11.74×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−USD 149.27 million
Exact value

Exact value: -149269000 USD

2024-01-01 – 2024-12-31: -149269000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 82.44 million
Exact value

Exact value: -82437000 USD

2024-01-01 – 2024-12-31: -82437000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6,000
Exact value

Exact value: 6000 USD

2024-01-01 – 2024-12-31: 6000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 82.44 million
Calculation and evidence

-82437000 − 6000 USD

Exact free cash flow: -82443000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 660.05 million
Exact value

Exact value: -660047000 USD

2025-01-01 – 2025-12-31: -660047000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 102.68 million
Exact value

Exact value: -102675000 USD

2025-01-01 – 2025-12-31: -102675000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 901,000
Exact value

Exact value: 901000 USD

2025-01-01 – 2025-12-31: 901000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 103.58 million
Calculation and evidence

-102675000 − 901000 USD

Exact free cash flow: -103576000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

7 filings · 415 latest values · 415 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002081043, 2081043, ATAI, edgar:2081043

Also known as ATAI LIFE SCIENCES LUXEMBOURG S.A., ATAIBECKLEY INC., AtaiBeckley Inc., atai Life Sciences Luxembourg S.A.